We describe LincSNP 2.0 (http://bioinfo.hrbmu.edu. cn/LincSNP), an updated database that is used specifically to store and annotate disease-associated single nucleotide polymorphisms (SNPs) in human long non-coding RNAs (lncRNAs) and their transcription factor binding sites (TFBSs). In LincSNP 2.0, we have updated the database with more data and several new features, including (i) expanding diseaseassociated SNPs in human lncRNAs; (ii) identifying disease-associated SNPs in lncRNA TFBSs; (iii) updating LD-SNPs from the 1000 Genomes Project; and (iv) collecting more experimentally supported SNPlncRNA-disease associations. Furthermore, we developed three flexible online tools to retrieve and analyze the data. Linc-Mart is a convenient way for users to customize their own data. Linc-Browse is a tool for all data visualization. Linc-Score predicts the associations between lncRNA and disease. In addition, we provided users a newly designed, user-friendly interface to search and download all the data in Linc-SNP 2.0 and we also provided an interface to submit novel data into the database. LincSNP 2.0 is a continually updated database and will serve as an important resource for investigating the functions and mechanisms of lncRNAs in human diseases.
INTRODUCTION
An abundant class of non-coding RNAs known as long non-coding RNAs (lncRNAs), defined by having a length exceeding 200 nucleotides, have gained widespread attention in recent years (1) . LncRNAs are widely encoded by the human genome and perform important functions in a spectrum of biological processes such as genome regulation, cell differentiation and development (2) (3) (4) . Accumulating evidence indicates that lncRNAs are closely associated with many human diseases (5, 6) .
In the emerging field of lncRNA research, many researchers have continued to focus on the influence of genetic variants on lncRNA function. A number of single nucleotide polymorphisms (SNPs), the most common type of genetic variant, have been identified in human lncRNA regions and have been shown to be associated with various diseases including cancers (7, 8) . In order to facilitate the study of lncRNA-related genetic variants, we reported the first version of the LincSNP database (LincSNP 1.0) that allows users to search all known disease-associated SNPs in human lncRNAs, together with their comprehensive functional annotations (9) . Although LincSNP 1.0 has provided some useful information for researchers, this database could provide more resources and be more user friendly. For example, LincSNP 1.0 only focused on large intergenic noncoding RNA (lincRNA), a subclass of lncRNAs and did not identify disease-associated SNPs in lncRNA regulatory elements such as transcription factor binding sites (TFBSs). Previous studies have demonstrated that the SNPs in lncRNA TFBSs could affect lncRNA expression, thereby potentially affecting disease susceptibility (10) . With the increasing amount of lncRNA and SNP data, there is a great need to update LincSNP 1.0 with more resources and improved tools.
To date, many databases have been built to curate lncRNA-related information, such as NONCODE (11), DIANA-LncBase (12), LNCipedia (13), lncRNAdb (14) , LncRNAWiki (15), ChIPBase (16), starBase (17) , LncRNADisease (18) and Lnc2Cancer (19) . These databases have provided valuable resources for lncRNA-related studies. However, there are very few databases that pay special attention to the relationship between SNPs and human lncRNAs. To our knowledge, only the lncRNASNP database stores lncRNA-related SNPs (20) . However, this database focuses mainly on exploring the impact of SNPs on lncRNA structure and function, and only a small number of disease-associated SNPs have been identified in hu-man lncRNAs. Until now, no specialized resource has been devoted to collecting, storing and distributing diseaseassociated SNPs in human lncRNAs.
To meet these needs, we have updated LincSNP (9) to version 2.0 (LincSNP 2.0) ( Figure 1 and Table 1 ). In Linc-SNP 2.0, the numbers of disease-associated SNPs and human lncRNAs have been increased to 809 451 and 244 545, respectively, and the number of types of lncRNA has been increased to 9. For the first time, disease-associated SNPs in lncRNA TFBSs were identified and included in LincSNP 2.0. Furthermore, the number of experimentally supported SNP-lncRNA-disease associations has grown from 3 to 58. In addition to the expansion of the core data sets, both the data search and download functions were improved. In particular, three web-based tools have been developed to facilitate data analysis, extraction and visualization. We hope that researchers will benefit from the greater resources in the updated version of LincSNP 2.0.
IMPROVED CONTENT AND NEW FEATURES

Expanded entries on disease-associated SNPs in human lncRNAs
Recent advances in high-throughput sequencing technology such as RNA-Seq have produced large numbers of lncRNAs (21) . There has also been a rapid increase of GWAS data in public databases (22) . This information provides us with a great opportunity to identify more diseaseassociated SNPs in human lncRNAs (Table 1 ). In Linc-SNP 2.0, the lncRNA sources have expanded from 1 to 5 databases, including Ensembl (Version 75), LncRBase (Version 1.0), NONCODE (Version 4), LNCipedia (Version 3.1) and GENCODE (Version 19). To provide a universal lncRNA annotation for users, lncRNA transcripts downloaded from different sources were considered to be the same transcript if they had the same positions. Then, each lncRNA transcript was named using serial numbers after the 'LSLNC' symbol. In total, we obtained 244 545 human lncRNAs and their annotations, and the number of types of lncRNA increased to 9 (including lincRNA, 3 overlapping ncRNA, antisense, processed transcript, exonic, retained intron, sense no exonic, sense intronic and sense overlapping).
The set of human GWAS databases storing disease (traits)-associated SNPs has been expanded from 6 to 8 sources, including dbGaP (23), GAD (24), GWAS Central (25), Johnson and O'Donnell (26) , the NHGRI GWAS Catalog (27) , PharmGKb (28), GWASdb (Version 2) (22) and GRASP (Version 2) (29) . As the integrated strategy in Linc-SNP 1.0, disease-associated SNPs were selected from original publications with moderate thresholds (P-values < 1.0 × 10 −3 ) and only the most significant SNP was selected in cases where the same SNP could be obtained from different publications (9) . In total, 809 451 unique disease-associated SNPs were collected. We also extracted SNPs that had linkage disequilibrium (LD-SNP, r 2 ≥ 0.8) relationships with disease-associated SNPs from the 1000 Genomes Project (Phase I version 3). After LD analysis by VCFtools (30), ∼11.6 million LD-SNPs were collected in LincSNP 2.0. Finally, we identified 371 647 disease-associated SNPs located in 145 642 human lncRNAs and we identified 1 266 485 LDSNPs in 168 915 human lncRNAs.
Newly added data on disease-associated SNPs in lncRNA TFBSs
We recently developed a database named SNP@lincTFBS to identify SNPs in potential TFBSs of human lincRNAs (31) . The updated LincSNP 2.0 has integrated SNP@lincTFBS as an important resource for the functional annotation of SNPs in lncRNA TFBSs. Briefly, we downloaded ChIP-Seq data sets for human transcription factors and identified the peaks located in the promoter regions of human lncRNAs (5 kb upstream to 1 kb downstream region of the transcription start site for each lncRNA) (32) 
Updated entries on experimentally supported SNP-lncRNAdisease associations
To provide a reliable source for the associations between lncRNA-related SNPs and disease, we developed a new page, Linc-Confirm, to store all experimentally supported SNP-lncRNA-disease associations. All experimentally supported SNP-lncRNA-disease associations were manually collected through several steps, as previously described (33) (34) (35) . First, we downloaded all published literature through searching the PubMed database (36) with a list of keywords (before July 2016), such as 'lncRNA SNP disease,' 'long non-coding RNA SNP disease,' 'lncRNA SNP cancer,' 'lncRNA SNP tumor' and 'long noncoding RNA polymorphism disease.' Second, experimentally supported SNP-lncRNA-disease associations were manually curated from published papers by at least two researchers. We retrieved the lncRNA, SNP and disease name, experimental samples and methods, PubMed ID, paper title and a brief description from the original studies. Third, all selected studies were rechecked for the lncRNA, SNP and disease names and some names were replaced with official or recommended names. In LincSNP 2.0, the number of experimentally supported SNP-lncRNA-disease associations has increased significantly, from 3 to 58 entries.
Linc-Mart tool for data discovery and access
Because of the large increase in the number of data entries, a new data access tool called Linc-Mart was developed to implement a customized data access pipeline for users. There are three options on the Linc-Mart page: selected project (Disease SNP -LncRNA or Disease SNPLncRNA TFBS), chromosome and lncRNA annotation information. Users can upload an e-mail address, and LincMart will process the file using a series of tunable criterion and filter steps based on the above options.
Linc-Browse tool for customized data views
Compared with LincSNP 1.0, we improved the LincSNP 2.0 architecture by adding the Linc-Browse tool to display important annotation tracks. Linc-Browse is a web-based genome browser that dynamically displays different tracks 
Linc-Score page for predicting disease-associated lncRNAs
In LincSNP 2.0, we developed a page called Linc-Score, which was used to predict potential lncRNA-disease associations based on genetic mutations. For each lncRNA and each specific disease, we counted the number of diseaseassociated SNPs located in this lncRNA region and TFBSs, including both disease-associated SNPs and their LD SNPs. We then calculated the top three potential lncRNAdisease associations for each lncRNA based on the number of disease-associated SNPs. We hope that this direct calculation can capture the lncRNAs most likely to be involved in specific diseases, providing disease lncRNA candidates for researchers.
DATABASE CONSTRUCTION AND IMPROVED USER INTERFACE
All data in LincSNP 2.0 were stored and managed using MySQL (version 5. 
CONCLUSIONS AND FUTURE DEVELOPMENT
When we developed the first version of the LincSNP database (LincSNP 1.0), only a limited number of diseaseassociated SNPs had been identified in human lncRNAs.
With the very fast growth of identified lncRNAs and disease-associated SNPs, there is a great need to update the LincSNP database. In LincSNP 2.0, more diseaseassociated SNPs in human lncRNAs were identified and annotated. To improve the functions of data processing and database access, three web-based tools, Linc-Mart, LincBrowse and Linc-Score, were developed. Moreover, we used ChIP-Seq data sets to identify disease-associated SNPs in the TFBSs of lncRNAs. We expect that the number of disease-associated SNPs mapped to lncRNAs and their TFBSs will continue to increase rapidly in the future releases of the LincSNP database. We will continually maintain and update the LincSNP database and integrate more data sets into the LincSNP database, such as cancer genomics data and clinical information, which will improve our understanding of the function of lncRNAs in human diseases. 
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